Blueclinical R&D’s mission is to partner with institutions and companies in the development of successful translational medicine projects.
Blueclinical R&D has a unique expertise and experience in translational medicine and drug development. Our experience includes:
Blueclinical supports sponsors in the definition of the target product profile and the definition of preclinical and regulatory plans.
A Blueclinical R&D is prepared to provide qualified “full services”:
When clinical trials require multinational participation, the partnership between Blueclinical Ltd and SCOPE International AG allows expedite patient recruitment everywhere in Europe and North America.
The SCOPE International AG head office is Mannheim in Germany, with offices in 17 European countries and USA, covering 25 countries by own 138 full-time CRAs. With experience in neuroscience, psychiatry, pain/ analgesia, respiratory, oncology, hematology, dermatology, women’s health, immunology, and infectious diseases. This partner has experience a global inspections by the FDA, EMA, BfArM and local GCP inspections in Austria, Germany, Latvia, Portugal, Romania, Russia, Serbia, Slovakia, and the United Kingdom.
High focus on providing cost-effective and regulatory-compliant studies, within short timelines and on-time delivery, to support the approval of your products by EMA, FDA and other regulatory authorities.
Blueclinical R&D is available to participate in international consortia candidate to Horizon 2020 calls or to other funding agencies.